Evidence does not support routine PSA testing, say expertsBMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f2982 (Published 09 May 2013) Cite this as: BMJ 2013;346:f2982
- Michael McCarthy
Screening asymptomatic men for prostate cancer with the prostate specific antigen (PSA) blood test should no longer be routine, say new guidelines issued by the American Urological Association.
The guidance is a marked shift from the association’s past recommendations, which generally favored more aggressive PSA screening, including offering PSA tests to men from age 40.
The new recommendations were drawn up by a panel of experts commissioned by the association to conduct a systematic review and meta-analysis of the published literature on prostate cancer detection and screening.1
The association’s previous 2009 best practice statement on PSA testing had been based on clinical experience and expert …